This page explains Spain’s system. Its licences, funding rules and prescribing criteria do not determine access in the UK.
Which official source answers whether the SNS funds a medicine?
The Ministry of Health's BIFIMED records financing; AEMPS CIMA provides the medicine's authorised product information.
Check CIMA for the exact product
AEMPS publishes Wegovy's product information, including its defined weight-management indication. The records distinguish formulations and presentations. A listing is useful evidence of authorisation, but it cannot establish stock in a particular pharmacy.
Check funding separately
The November 2026 BIFIMED record reviewed for Wegovy 0.5 mg FlexTouch marks that presentation as not financed by resolution. Check the exact presentation and indication when discussing payment; do not transfer diabetes funding assumptions to obesity care.
Quantity changes the comparison
A price per pen can be misleading when presentations contain different quantities. Ask the pharmacy to identify the prescribed pack and how long it is intended to last. Add consultation and follow-up charges when comparing private services.
A useful distinction for UK readers
Spain's separate product and financing databases show why a regulatory listing cannot settle a funding question. For UK care, the corresponding checks are MHRA product information and the relevant NHS pathway. Spanish financing status does not establish either.
Keep these four questions separate
Access
Spanish medical assessment and dispensing context
Funding
BIFIMED records financing by presentation and indication
Cost context
Spanish EUR pack prices are not UK service quotes
Regulatory source
AEMPS; EU authorisation framework
Sources & further reading
Sources checked . These links support the information above; they do not imply endorsement of this website.
Written for a UK audience by the Health Comparisons editorial team. This page is an information resource and has not been presented as a clinician’s personal recommendation. Discuss treatment decisions with your prescriber.
Read our editorial standards →
Compare prices